Immunology

H. von Boehmer, P. Kisielow, "Self-nonself discrimination by T cells," Science, 248:1369-73, 1990. Harald von Boehmer (Basel Institute for Immunology, Switzerland): "Despite 100 years of debate and speculation, the principles and mechanism of the self-nonself discrimination process by the immune system until recently have been obscure. Experimental analyses were hindered by the tremendous diversity of immunologic cells and receptor molecules. By creating T cell receptor transgenic mice--mice w

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share


H. von Boehmer, P. Kisielow, "Self-nonself discrimination by T cells," Science, 248:1369-73, 1990.

Harald von Boehmer (Basel Institute for Immunology, Switzerland): "Despite 100 years of debate and speculation, the principles and mechanism of the self-nonself discrimination process by the immune system until recently have been obscure. Experimental analyses were hindered by the tremendous diversity of immunologic cells and receptor molecules. By creating T cell receptor transgenic mice--mice whose immune system produces only one receptor--we were able to answer questions about the discrimination between self and nonself in previously impossible detail.

"We have learned that the immature immune system produces cells that would attack every tissue in the body. At the same time, it would also produce cells that, while not harmful, would be useless to the organism. Within the thymus gland, however, the immune system learns which cells would be harmful, useless, or useful to preserve, and acts accordingly."

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies